Press Releases 
Frost & Sullivan Recognizes Transport Pharmaceuticals Innovative Electrokinetic Drug Delivery Platform for Contributing to Clinical Outcomes
Dec 10, 2007
Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
Dec 06, 2007
Transport's Phase 2 Data Show Single Treatment SoloVir™ ETS Significantly Stops Progression of Cold Sore Episode
Nov 28, 2007
Transport Pharmaceuticals Initiates Patient Enrollment in Phase 2 Study of Solovir System for Herpes Labialis
May 1, 2007
Brian M. Gallagher Joins Transport Pharmaceutical's Board of Directors
April 10, 2007
Transport Extends its Scientific Advisory Board with Appointments of Drug Development & Delivery
March 20, 2007
Transport Delivers Unprecedented Levels of Acyclovir with Novel Five Percent Gel Formulation
February 8, 2007
Transport Pharmaceuticals hires Vice President of Quality and Operational Excellence
October 3, 2006
Phase IIb Clinical Results Published in Journal of Clinical Infectious Diseases
August 15, 2006
Dennis Goldberg Appointed to CEO of Transport Pharmaceuticals
August 14, 2006
Transport Pharmaceuticals Raises $12.6 M in Venture Financing
July 31, 2006
Transport Pharmaceuticals Names Sean Moran Chief Financial Officer
June 29, 2006
Specialty Pharma Magazine Article
 View PDF
Media Inquiries, please contact:
Bryan Murphy
Vice President, Public Relations
LaVoie Group
Phone: 978-745-4200 x105
Email: bmurphy@lavoiegroup.com
back to top
|